The global Ocular Drug Delivery market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Ocular Drug Delivery volume and value at global level, regional level and company level. From a global perspective, this report represents overall Ocular Drug Delivery market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Ocular Drug Delivery in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Ocular Drug Delivery manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
OCULAR THERAPEUTIX, INC
Alimera Sciences
Allergan, Plc
EyeGate Pharma
Valeant Pharmaceuticals International, Inc
Envisia Therapeutics
Clearside Biomedical
Graybug Vision Inc
Taiwan Liposome Company
Santen Pharmaceutical Co., Ltd

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
By Technology
Ocular Insert
Iontophoresis
Intraocular Implants
In Situ Gel & Punctal Plugs
Others
By Form
Solution
Suspension
Emulsion
Liposomes & Nanoparticles
Ointment

Segment by Application
Hospitals
Ambulatory Surgical Centers
Ophthalmic Clinics
Homecare Settings